Novo Nordisk A/S (OTC Pink - Current Information:NONOF)
| 91.08 Delayed Data As of Sep 29 |  -0.58 / -0.63%Today’s Change | 48.68 Today|||52-Week Range 100.99 | +33.43% Year-to-Date |
Latest NONOF News | Press Releases
Today’s Trading
| Previous close | 91.65 |
| Today’s open | 91.50 |
| Day’s range | 90.74 - 92.77 |
| Volume | 2,714 |
| Average volume (3 months) | 42,161 |
| Market cap | $312.9B |
Data as of 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +4.77% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +11.71% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 34.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -0.83 | -0.56% |
| MRKMerck | -0.39 | -0.38% |
| JNJJohnson & Johnson | -0.63 | -0.40% |
| NVSNovartis | -0.33 | -0.32% |
Data as of 4:00pm ET, 10/02/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $25.0B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 31.38% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bagsværd, Capital Region |
Forecasts
Chart unavailable
